The Enterprise Value as of December 2025 (TTM) for Xspray Pharma AB (publ) (XSPRAY.ST) is 1.09B

According to Xspray Pharma AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 1.09B. This represents a change of -33.54% compared to the average of 1.64B of the last 4 quarters.

Xspray Pharma AB (publ) (XSPRAY.ST) Historical Enterprise Value (quarterly & annually)

How has XSPRAY.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Xspray Pharma AB (publ) over the last ten years is 1.00B. The current 1.09B Enterprise Value has changed 10.75% with respect to the historical average. Over the past ten years (40 quarters), XSPRAY.ST's Enterprise Value was at its highest in in the December 2020 quarter at 2.95B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Xspray Pharma AB (publ) (XSPRAY.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xspray Pharma AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xspray Pharma AB (publ) (XSPRAY.ST) Average Enterprise Value

How has XSPRAY.ST Enterprise Value performed in the past?

The current Enterprise Value of Xspray Pharma AB (publ) (XSPRAY.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Xspray Pharma AB (publ) (XSPRAY.ST) Enterprise Value vs. Peers

How is XSPRAY.ST’s Enterprise Value compared to its peers?

Xspray Pharma AB (publ)’s Enterprise Value is greater than Cantargia AB (publ) (756.00M), less than Orexo AB (publ) (1.25B), greater than I-Tech AB (518.33M), greater than Infant Bacterial Therapeutics AB (publ) (485.65M), greater than Senzime AB (publ) (730.08M), less than Oncopeptides AB (publ) (1.09B), greater than Mendus AB (publ) (215.77M), greater than SynAct Pharma AB (1.02B), greater than Sedana Medical AB (publ) (943.08M), greater than Ascelia Pharma AB (publ) (278.52M),

Build a custom stock screener for Xspray Pharma AB (publ) (XSPRAY.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xspray Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xspray Pharma AB (publ) (XSPRAY.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xspray Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.